MARKET

AYLA

AYLA

Ayala Pharmaceuticals, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.410
-0.090
-6.00%
Pre Market: 1.470 +0.06 +4.26% 09:11 08/11 EDT
OPEN
1.410
PREV CLOSE
1.500
HIGH
1.450
LOW
1.290
VOLUME
1.07K
TURNOVER
0
52 WEEK HIGH
14.95
52 WEEK LOW
0.7000
MARKET CAP
19.86M
P/E (TTM)
-0.5137
1D
5D
1M
3M
1Y
5Y
Here's Why We're A Bit Worried About Ayala Pharmaceuticals' (NASDAQ:AYLA) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Simply Wall St. · 1d ago
Snowflake, Oatly Group among premarket losers' pack
Eliem Therapeutics ELYM -25% on report to <a href="https://seekingalpha.com/news/3864536-elym-stock-on-watch-on-plans-to-discontinue-development-of-lead-asset?utm_medium=referral&utm_source=webull.com" target="_blan...
Seekingalpha · 08/02 12:39
Thinking about buying stock in Ayala Pharmaceuticals, Kaltura, Plug Power, Ford Motor, or FuelCell Energy?
InvestorsObserver issues critical PriceWatch Alerts for AYLA, KLTR, PLUG, F, and FCEL.
PR Newswire · 07/29 13:39
XELA, NWG and TBLT are among pre market gainers
Ayala Pharmaceuticals (AYLA) +51%. Senti Biosciences (<a hr...
Seekingalpha · 07/29 12:48
AUPH, SBFM and AYLA among pre market losers
OBsEVA (OBSV) -73% <a href="https://seekingalpha.com/news/3861214-obsv-stock-drops-on-pl...
Seekingalpha · 07/27 12:37
Nasdaq Tumbles 200 Points; McDonald's Posts Upbeat Q2 Earnings
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 200 points on Tuesday.
Benzinga · 07/26 16:30
Mercury Systems (MRCY) Stock Falls on New Short Report
Investor Place · 07/26 15:59
Why Is Ayala Pharmaceuticals (AYLA) Stock Up 100%+ Today?
Investor Place · 07/26 15:22
More
No Data
Learn about the latest financial forecast of AYLA. Analyze the recent business situations of Ayala Pharmaceuticals, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

28.57%Strong Buy
71.43%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average AYLA stock price target is 13.38 with a high estimate of 18.00 and a low estimate of 6.00.
High18.00
Average13.38
Low6.00
Current 1.420
EPS
Actual
Estimate
-0.64-0.48-0.32-0.16
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 18
Institutional Holdings: 5.58M
% Owned: 39.65%
Shares Outstanding: 14.09M
TypeInstitutionsShares
Increased
6
75.14K
New
2
83.11K
Decreased
4
324.81K
Sold Out
1
1.94K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
No Data
About AYLA
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The Company's portfolio of product candidates, AL101 and AL102, targets the aberrant activation of the Notch pathway using gamma secretase inhibitors (GSIs). AL101 and AL102 are designed to address the underlying key drivers of tumor growth. The Company is evaluating AL101 as a monotherapy in an open-label Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma (R/M ACC), for patients bearing Notch-activating mutations. The Company also developing AL102 for the treatment of other rare indications including T-ALL, an aggressive, rare form of T-cell specific leukemia. The Company is also conducting its ongoing Phase II ACCURACY trial for the treatment of R/M ACC in subjects with progressive disease and Notch-activating mutations.

Webull offers kinds of Ayala Pharmaceuticals Inc stock information, including NASDAQ:AYLA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AYLA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AYLA stock methods without spending real money on the virtual paper trading platform.